Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) Study

NCT01971606 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

234

Enrollment

OTHER

Sponsor class

Conditions

A Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB.

Interventions

DRUG: Rosuvastatin

Sponsor

Yonsei University